ACS Chemical BiologyBiochemistryPeer-reviewed journal article
Chemokine-binding all-D-CLIPS™ peptides identified using mirror-image phage display
Stepan S. DenisoviD, Emilia Laura BialekiD, Fabio BerettaiD, Gintare Smagurauskaite, Hans IppeliD, Eline Fijlstra, Sangram S. KaleiD, Peter TimmermaniD, Tilman M. HackengiD, Paul ProostiD, Michael GoldflamiD, Ingrid DijkgraafiD
Abstract
Chemokines are secreted blood proteins, which steer leukocyte migration in the inflammatory response. Neutralization of chemokines is believed to be a beneficial therapeutic strategy for the treatment of inflammation-associated diseases. Proteolytically stable chemokine-binding peptides could be suitable candidates for the development of chemokine-neutralizing agents. Here, we report mirror-image phage display selection of cyclic all-D-peptides against the C-X-C motif chemokine ligand 8 (CXCL8). Selection yielded structurally diverse all-D-peptides with sub-micromolar affinity to the target CXCL8 chemokine and different selectivity to related chemokines. Binding of these all-D-peptides caused dissociation of the native CXCL8 dimer and disruption of its binding to GAGs, without effect on in vitro cell migration. This work demonstrates the example of mirror-image phage display selection of cyclized all-D-peptides and its utility for the development of chemokine-binding agents.
- Citations
- 2
- FWCI
- 0.60
- Field percentile
- top 36%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Crosslinking-guided geometry of a complete CXC receptor-chemokine complex and the basis of chemokine subfamily selectivity
T. Ngo, B. S. Stephens, … I. Kufareva·bioRxiv·Jan 10, 2020
- Systematic development of peptide inhibitors targeting the CXCL12/HMGB1 interaction
J. Sgrignani, V. Cecchinato, … A. Cavalli·bioRxiv·Dec 18, 2019
- Selective suppression and biasing of chemokine receptors CCR9 and ACKR4 through targeting CCL25 with de novo miniproteins
Bas De Boer, Thomas D Lamme, … Christopher T. Schafer·bioRxiv·Oct 5, 2026
- De novo macrocyclic peptide discovery produces potent class A GPCR ligands with diverse pharmacology
Fernando Salgado-Polo, Marin Matic, … Martin B Gustavsson·bioRxiv·Oct 22, 2026
- Selection of potent biologic antagonists of the cannabinoid GPCR CB2R from a constrained peptide library
Robert S. Leddy, Ajay Pal, … David J O’Connell·bioRxiv·Jul 3, 2026
- A phage display approach to identify highly selective covalent binders